ClinConnect ClinConnect Logo
Search / Trial NCT06983652

Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema

Launched by SINGAPORE EYE RESEARCH INSTITUTE · May 14, 2025

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Cornea Corneal Scar Corneal Edema Terahertz Hydration

ClinConnect Summary

This clinical trial is studying a new technology called the Terahertz (THz) scanning system to see how well it can evaluate corneal scars and corneal edema, which are conditions affecting the eye's clear front surface, the cornea. Researchers want to find out if this new scanning method can accurately measure the hydration levels in the cornea and track how these conditions change over time compared to traditional eye exams.

To participate, you need to be at least 21 years old and have either corneal scars or corneal edema, but not both at the same time. You should also be able to follow study instructions and keep your face steady for the scans. If you’re interested, you will undergo THz scanning followed by standard eye exams to gather detailed information about your condition. It’s important to know that individuals with active eye infections, pregnancy, or certain other health issues may not be eligible for this trial. This study is currently looking for participants, so if you think you qualify, it could be a great opportunity to contribute to eye health research!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be at least 21 years of age.
  • Regardless of gender (Male/Female).
  • Regardless of race (Chinese/Malay/Indian/Eurasian/Others).
  • Willingness and ability to follow all instructions and comply with study schedule for study visit.
  • Patients with corneal endothelial dysfunction (Fuchs' endothelial dystrophy or other causes of bullous keratopathy) at any disease stage OR Patients with corneal scars from any cause, with the absence of corneal edema.
  • Ability to hold face sufficiently stable to undergo necessary scans.
  • Exclusion Criteria:
  • Eyes with active inflammation or infection, or chronic ocular surface inflammation
  • Unable to give consent
  • Physically immobile/poor instructional compliance
  • PI determined
  • Pregnant/ breast feeding women

About Singapore Eye Research Institute

The Singapore Eye Research Institute (SERI) is a leading clinical research organization dedicated to advancing the understanding and treatment of eye diseases. As a collaborative institute affiliated with the National University of Singapore and the Singapore Health Services, SERI focuses on innovative research and clinical trials that aim to improve patient outcomes in ophthalmology. With a multidisciplinary team of experts, SERI is committed to translating scientific discoveries into effective therapies and enhancing the quality of eye care through rigorous research initiatives and community engagement.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported